rs11558754

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002340.6(LSS):​c.363C>T​(p.Ala121Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,613,614 control chromosomes in the GnomAD database, including 20,596 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1646 hom., cov: 34)
Exomes 𝑓: 0.16 ( 18950 hom. )

Consequence

LSS
NM_002340.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.17

Publications

8 publications found
Variant links:
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]
LSS Gene-Disease associations (from GenCC):
  • alopecia-intellectual disability syndrome 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cataract 44
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypotrichosis 14
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • hypotrichosis simplex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive palmoplantar keratoderma and congenital alopecia
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 21-46222695-G-A is Benign according to our data. Variant chr21-46222695-G-A is described in ClinVar as Benign. ClinVar VariationId is 677219.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.18 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LSSNM_002340.6 linkc.363C>T p.Ala121Ala synonymous_variant Exon 4 of 22 ENST00000397728.8 NP_002331.3
LSSNM_001001438.3 linkc.363C>T p.Ala121Ala synonymous_variant Exon 4 of 23 NP_001001438.1
LSSNM_001145436.2 linkc.363C>T p.Ala121Ala synonymous_variant Exon 4 of 22 NP_001138908.1
LSSNM_001145437.2 linkc.123C>T p.Ala41Ala synonymous_variant Exon 3 of 21 NP_001138909.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LSSENST00000397728.8 linkc.363C>T p.Ala121Ala synonymous_variant Exon 4 of 22 1 NM_002340.6 ENSP00000380837.2 P48449-1

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21859
AN:
152176
Hom.:
1644
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.133
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.0987
Gnomad SAS
AF:
0.0890
Gnomad FIN
AF:
0.0881
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.169
Gnomad OTH
AF:
0.154
GnomAD2 exomes
AF:
0.136
AC:
34011
AN:
250330
AF XY:
0.137
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.122
Gnomad ASJ exome
AF:
0.121
Gnomad EAS exome
AF:
0.101
Gnomad FIN exome
AF:
0.0881
Gnomad NFE exome
AF:
0.166
Gnomad OTH exome
AF:
0.144
GnomAD4 exome
AF:
0.158
AC:
230683
AN:
1461320
Hom.:
18950
Cov.:
32
AF XY:
0.157
AC XY:
113788
AN XY:
726954
show subpopulations
African (AFR)
AF:
0.134
AC:
4498
AN:
33474
American (AMR)
AF:
0.123
AC:
5487
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
3253
AN:
26132
East Asian (EAS)
AF:
0.0899
AC:
3568
AN:
39698
South Asian (SAS)
AF:
0.103
AC:
8904
AN:
86250
European-Finnish (FIN)
AF:
0.0945
AC:
5014
AN:
53070
Middle Eastern (MID)
AF:
0.176
AC:
1016
AN:
5768
European-Non Finnish (NFE)
AF:
0.171
AC:
189797
AN:
1111834
Other (OTH)
AF:
0.151
AC:
9146
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
10401
20802
31202
41603
52004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6676
13352
20028
26704
33380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.144
AC:
21875
AN:
152294
Hom.:
1646
Cov.:
34
AF XY:
0.138
AC XY:
10270
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.133
AC:
5527
AN:
41560
American (AMR)
AF:
0.137
AC:
2097
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
417
AN:
3472
East Asian (EAS)
AF:
0.0985
AC:
510
AN:
5176
South Asian (SAS)
AF:
0.0892
AC:
431
AN:
4830
European-Finnish (FIN)
AF:
0.0881
AC:
936
AN:
10622
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.169
AC:
11465
AN:
68014
Other (OTH)
AF:
0.154
AC:
325
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
977
1954
2932
3909
4886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
801
Bravo
AF:
0.149
Asia WGS
AF:
0.106
AC:
370
AN:
3478
EpiCase
AF:
0.167
EpiControl
AF:
0.173

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LSS-related disorder Benign:1
Jul 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.55
DANN
Benign
0.90
PhyloP100
-4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11558754; hg19: chr21-47642609; COSMIC: COSV62701950; COSMIC: COSV62701950; API